Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies

NCT: NCT05134311 · RECRUITING

NCT IDNCT05134311
StatusRECRUITING
Start Date2025-07-01
Completion2028-09-01
SponsorNorthwell Health (OTHER)
First posted
Last updated

Brief Summary

The ability to have a visual aid to depict areas of vascular disease that are affecting the patient's health can help in patient comprehension of the problem. This comprehension can lead to better understanding of the issue and increase patient compliance to treatment. The hand drawn sketch produced by the ultrasound technologist provides an inadequate visualization of the vascular insufficiency that is causing the patient's symptoms. PIUR imaging has developed PIUR Infinity tUS, a 3D freehand tomographic ultrasound system capable of rapid, safe and accurate reconstructive 3D quantifiable vascular imaging. This system will provide a low cost and reproducible imaging solution that will be an effective educational tool for people with vascular disease.

Frequently Asked Questions

What is Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies?

Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies is a clinical trial registered under NCT05134311. Current status: RECRUITING.

What is the status of NCT05134311?

The current status of NCT05134311 (Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies) is: RECRUITING.

When did Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies start?

Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies started on 2025-07-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.